Shutterly Andrew

Altimmune, Inc. · Acting Chief Financial Officer

Shutterly Andrew is listed in filings as Acting Chief Financial Officer at Altimmune, Inc.. This profile follows SEC Form 4 activity through Aug 1, 2024, including 1 public disclosure. Recent filings connect the profile to Altimmune, Inc. (ALT). The current snapshot covers public activity from Aug 1, 2024. Reported amounts are shown as $6.8K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.

Data sources and methodology

Latest Trades

CompanyValueActionPriceCurrent Price
No direct insider buys or sells are available yet.
Shutterly Andrew insider trades and Form 4 filings | TradingNote